Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease

Eisai

Status: Completed

Conditions: Alzheimer's Desease

Treatments: Drug: Donepezil Hydrochloride

Study type: Observational

Funder types: Industry

Identifiers

NCT02162251

ART07T

Details and patient eligibility

About

To investigate the safety and effectiveness about administration of both donepezil hydrochloride and menatine hydrochloride in patients with Alzheimer's Disease in clinical practice.

Enrollment: 3,482 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

Patients diagnosed with Alzheimer's Disease who are to be administered both donepezil hydrochloride and memantine hydrochloride in clinical practice.

Exclusion criteria

Patients with a history of hypersensitivity to any ingredients of Aricept or piperidine derivatives.

Trial design

3,482 participants in 1 patient group

E2020

Treatment:

Drug: Donepezil Hydrochloride